Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc. - PE Ratioverified

SNSE

Price:

$13.85

Market Cap:

$23.91M

Sensei Biotherapeutics, Inc. (SNSE) is a biopharmaceutical firm dedicated to discovering and advancing immunotherapies, primarily for cancer treatment. The company's innovative approaches include its proprietary ImmunoPhage platform. This immunotherapy leverages bacteriophages to orchestrate a precise and robust innate and adaptive immune response. They also employ the Tumor Microenvironment Activated Biologics (TMAB) platform. This system is engineered to unleash T-cells' anti-tumor capabilities, utilizing human monoclonal antibodies specifically designed to operate within the tumor's immediate environment and target key immune checkpoints or other crucial signaling pathways. Sensei Biother...[Read more]

Industry

Biotechnology

IPO Date

2021-02-04

Stock Exchange

NASDAQ

Ticker

SNSE

The PE Ratio as of June 2026 (TTM) for Sensei Biotherapeutics, Inc. (SNSE) is -0.10

According to Sensei Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -74.36% compared to the average of -0.39 of the last 4 quarters.

Sensei Biotherapeutics, Inc. (SNSE) Historical PE Ratio (quarterly & annually)

How has SNSE PE Ratio performed in the past?

The mean historical PE Ratio of Sensei Biotherapeutics, Inc. over the last ten years is -161.48. The current -0.10 PE Ratio has changed -93.81% with respect to the historical average. Over the past ten years (40 quarters), SNSE's PE Ratio was at its highest in in the March 2026 quarter at -0.06. The PE Ratio was at its lowest in in the December 2020 quarter at -350.00.

Quarterly (TTM)
Annual

Average

-161.48

Median

-19.36

Minimum

-581.54

Maximum

-0.64

Sensei Biotherapeutics, Inc. (SNSE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sensei Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.83%

Maximum Annual PE Ratio = -0.64

Minimum Annual Increase = -92.19%

Minimum Annual PE Ratio = -581.54

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.64-92.19%
2024-8.17-28.01%
2023-11.34-39.85%
2022-18.86-78.38%
2021-87.22-84.54%
2020-564.18-2.99%
2019-581.542.83%

Sensei Biotherapeutics, Inc. (SNSE) Average PE Ratio

How has SNSE PE Ratio performed in the past?

The current PE Ratio of Sensei Biotherapeutics, Inc. (SNSE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.72

5-year avg

-25.25

10-year avg

-161.48

Sensei Biotherapeutics, Inc. (SNSE) PE Ratio vs. Peers

How is SNSE’s PE Ratio compared to its peers?

Sensei Biotherapeutics, Inc.’s PE Ratio is greater than Imunon, Inc. (-0.31), greater than Bolt Biotherapeutics, Inc. (-0.25), greater than Evogene Ltd. (-0.38), greater than Cocrystal Pharma, Inc. (-1.34), greater than Dogwood Therapeutics, Inc. (-0.15), greater than Marker Therapeutics, Inc. (-1.99), greater than Cellectar Biosciences, Inc. (-0.38), greater than AEON Biopharma, Inc. (-0.13), greater than Cingulate Inc. (-0.99), greater than Traws Pharma, Inc. (-0.98),

Build a custom stock screener for Sensei Biotherapeutics, Inc. (SNSE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sensei Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sensei Biotherapeutics, Inc. (SNSE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sensei Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sensei Biotherapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Sensei Biotherapeutics, Inc. (SNSE)?

What is the highest PE Ratio for Sensei Biotherapeutics, Inc. (SNSE)?

What is the 3-year average PE Ratio for Sensei Biotherapeutics, Inc. (SNSE)?

What is the 5-year average PE Ratio for Sensei Biotherapeutics, Inc. (SNSE)?

How does the current PE Ratio for Sensei Biotherapeutics, Inc. (SNSE) compare to its historical average?